Clinical Trial Results: A Proof-of-Concept Study to Assess Batoclimab in Participants With Graves' Disease [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept study evaluating batoclimab for Graves' disease has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Disease

Drugs mentioned

• Batoclimab (batoclimab)

Snippet

Sponsor: Immunovant Sciences GmbH | Conditions: Graves Disease | Phase 2 | Status: COMPLETED | Results posted: 2026-08-13